Iceland received the first doses of COVID-19 vaccine on December 28, 2020 and vaccination began the following day. As of April 2022, 79% of Iceland’s total population has been fully vaccinated, or 82% of the eligible population. Iceland began administering booster shots in late 2021 and offering vaccination for 5- to 11-year-olds in January 2022.
COVID-19 vaccination is optional and free of charge in Iceland. Vaccines were initially administered according to priority groups defined by health authorities, but the priority groups were abolished in June 2021 once all residents aged 16 and over had been offered vaccination.
All foreign residents in Iceland have access to vaccination regardless of residency status or whether or not they have a local ID number (kennitala).
Icelandic data shows that vaccinated individuals are less likely to contract the SARS-CoV-2 virus and that vaccines are very effective at staving off serious illness and hospitalisation due to COVID-19. Iceland’s Chief Epidemiologist Þórólfur Guðnason has stated that booster shots could help Iceland reach herd immunity. Local data shows that a third dose may increase protection against COVID-19 infection, transmission, and serious illness by 90%, as compared to just two doses.
Vaccines Through European Union
Iceland and other EFTA countries are guaranteed the same access to vaccines as member states of the European Union. The European Commission has signed contracts with six vaccine manufacturers, including AstraZeneca, Pfizer, and Moderna. The Commission negotiates the number of doses it receives from each manufacturer and they are divided among countries proportionally. Each individual country also makes contracts with vaccine manufacturers and EFTA member states such as Iceland do so through Sweden.
Below is the latest information on the status of all COVID-19 vaccines expected in Iceland.
This article will be regularly updated.